Jan. 14, 2025 A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings ...
BERKELEY, CA / ACCESS Newswire / July 6, 2026 / Helio Corporation (OTCID:HLEO) ("Helio" or the "Company"), a developer of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results